Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical use

Overview of attention for article published in BMC Medical Genomics, May 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 1 X user
patent: 2 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 35 Dimensions

Readers on

mendeley: 51 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

CELLS FOR IMMUNOTHERAPY ENGINEERED FOR TARGETING CD38 ANTIGEN AND FOR CD38 GENE…

Application WO-2017025323-A1

World Intellectual Property Organisation (WIPO)

USE OF ANTIBODIES AGAINST ICAM-1 IN THE TREATMENT OF PATIENTS WITH RELAPSED CANCER

Application EP-2593481-A1

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.